OPKO Health, Inc.
OPK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $713 | $863 | $1,004 | $1,775 |
| % Growth | -17.4% | -14% | -43.4% | – |
| Cost of Goods Sold | $402 | $545 | $716 | $1,193 |
| Gross Profit | $311 | $318 | $288 | $582 |
| % Margin | 43.6% | 36.8% | 28.7% | 32.8% |
| R&D Expenses | $105 | $90 | $74 | $77 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $304 | $301 | $373 | $469 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $54 | $85 | $68 | $17 |
| Operating Expenses | $463 | $475 | $514 | $563 |
| Operating Income | -$152 | -$157 | -$226 | $19 |
| % Margin | -21.3% | -18.2% | -22.5% | 1.1% |
| Other Income/Exp. Net | $142 | -$27 | -$166 | -$33 |
| Pre-Tax Income | -$10 | -$184 | -$392 | -$15 |
| Tax Expense | $43 | $4 | -$63 | $15 |
| Net Income | -$53 | -$189 | -$328 | -$30 |
| % Margin | -7.5% | -21.9% | -32.7% | -1.7% |
| EPS | -0.077 | -0.25 | -0.46 | -0.046 |
| % Growth | 69.3% | 45.7% | -911% | – |
| EPS Diluted | -0.077 | -0.25 | -0.46 | -0.046 |
| Weighted Avg Shares Out | 694 | 752 | 719 | 648 |
| Weighted Avg Shares Out Dil | 694 | 752 | 719 | 648 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $4 | $2 | $0 |
| Interest Expense | $47 | $14 | $12 | $19 |
| Depreciation & Amortization | $98 | $105 | $109 | $79 |
| EBITDA | $135 | -$66 | -$271 | $84 |
| % Margin | 19% | -7.6% | -27% | 4.7% |